XML 44 R33.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Schedule of Stock Option Activity and Weighted Average Exercise Prices
The following table summarizes the Company’s stock option activity and weighted-average exercise prices:
Number Of
Options
Outstanding
Weighted-
Average
Exercise Price
Weighted-
Average
Remaining
Contractual
Life (in Years)
Aggregate
Intrinsic Value
(in thousands)
Balance outstanding—December 31, 20246,953,119 $4.55 3.0$961,910 
Options granted— — 
Options exercised(1,316,133)1.29 
Options forfeited or expired— — 
Balance outstanding—March 31, 20255,636,986 $5.31 3.1$529,327 
Ending Exercisable—March 31, 2025
5,636,986 $5.31 3.1$529,327 
Schedule of Activity for Unvested RSUs
The following table summarizes the activity for the Company’s unvested RSUs and PSUs:
SharesWeighted-
Average Grant Date
Fair Value
Balance—December 31, 202413,806,700 $116.09 
Awarded1,100,652 117.98 
Vested(1,475,894)109.71 
Forfeited/canceled(322,309)114.80 
Balance—March 31, 202513,109,149 $116.99 
Schedule of Activity for Unvested PSUs
The following table summarizes the activity for the Company’s unvested RSUs and PSUs:
SharesWeighted-
Average Grant Date
Fair Value
Balance—December 31, 202413,806,700 $116.09 
Awarded1,100,652 117.98 
Vested(1,475,894)109.71 
Forfeited/canceled(322,309)114.80 
Balance—March 31, 202513,109,149 $116.99 
Schedule of Stock-based Compensation Expense
Stock-based compensation expense was included in the condensed consolidated statement of operations as follows (in thousands):
Three Months Ended
March 31,
20252024
Cost of revenue$6,651 $5,527 
Research and development105,735 88,413 
Sales and marketing34,125 28,531 
General and administrative17,754 12,562 
Stock-based compensation, net of amounts capitalized164,265 135,033 
Capitalized stock-based compensation expense5,662 2,646 
Total stock-based compensation expense$169,927 $137,679